Skip to content

Activ C European Multicenter Study

Activ C Disc Prosthesis European Multi-Center Clinical Investigation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02492724
Enrollment
210
Registered
2015-07-09
Start date
2007-02-28
Completion date
2013-12-31
Last updated
2015-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease, Intervertebral Disc Replacement

Keywords

cervical spine, total disc replacement (cTDR), degenerative disc disease, activ® C, clinical outcome, long-term results, NDI, VAS, heterotopic ossification (HO), range of motion (ROM), adjacent segment degeneration

Brief summary

Patients are candidates for single-level Artificial Disc Replacement between C3 and C7 who suffer from cervical symptomatic degenerative disc disease. A maximum of 200 cases will be enrolled into the study. An 18-month recruitment period is planned with a 4-year postoperative follow-up period for each subject. Thus, it is anticipated that the study will require a minimum of 5.5 years. Patients will be assessed preoperatively, intraoperatively, prior to discharge and again at 6 weeks, 6 months, 1 year, 2 years and 4 years postoperatively from the date of surgery.

Detailed description

The activ C Disc Prosthesis pursues the goal of restoring the disc function, the geometry and motion of the cervical disc. Its concept is based on a ball and socket joint, anchored between adjacent vertebral bodies. The modular prosthesis comprises the following elements: an inferior CoCr plate component anchored in the endplate of the caudal vertebral body. The UHMWPE inlay is securely fixed in this inferior component. The second element is the superior CoCr component, which is anchored in the end plate of the cranial vertebral body. It forms a ball joint with the inlay of the inferior plate component. The activ C product range enables reconstruction of various disc heights as well as adaptation to the end plate sizes. Secure primary anchorage of the prosthesis to the vertebral bodies is achieved by convexly shaped superior end pla tes and fixation means (spikes and grooves on the superior end plate, a small keel on the inferior end plate), whereas secondary stability is facilitated by an osseointegrative Plasmapore® coating. The objective of the study is to collect outcome information on the Activ® C Disc Prosthesis.

Interventions

None listed

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic single-level cervical degenerative disc disease with neck and/or arm * pain and/or neurological deficit, confirmed by MR scan * Single-level surgery and single-level implantation of prosthesis between C3 and C7 * Age between 18 - 65 years at the time of surgery * Pre-operative disc space height of the segment to be operated of at least 3mm * Unsuccessful adequate conservative treatment * Patient understands the conditions of the study and is willing and able to comply with the post-operative scheduled clinical and radiographic evaluations and the prescribed rehabilitation * Patient signed Informed Consent

Exclusion criteria

* Major facet joint degeneration at the segment to be operated on * Severe spondylosis at the segment to be operated on (bridging osteophytes, absence of motion (\<2°)) * Pre-operative disc space height of the segment to be operated on of less than 3mm * Major cervical segmental instability at the segment to be operated on (translation ≥3,5 mm and/or ≥11° of rotational difference to that of either adjacent level) * Previous trauma to the segment to be operated on resulting in compression or bursting

Design outcomes

Primary

MeasureTime frameDescription
Clinical Outcome measured by the Neck Disability Index (NDI)4 yearsThe primary endpoint of the study will be changes in the clinical outcome measured by the Neck Disability Index (NDI) as published by Vernon et. al.

Secondary

MeasureTime frame
Visual Analogue Scale (VAS) on frequency of neck pain and arm pain (experienced in the pain-dominant arm)4 years
Adjacent segment degeneration4 years
Visual Analogue Scale (VAS) on severity of neck pain and arm pain (experienced in the pain-dominant arm)4 years
Complication rates (device related and non-device related)4 years
Overall success rate4 years
Postoperative angular motion on flexion/extension radiographs in the replaced segment4 years

Countries

Czechia, Finland, Germany, Italy, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026